Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node RadiationMonika L. Metzger, Matthew J. Krasin, Michael P. Link et al.|Journal of Clinical Oncology|2021Cited by 59
Timing of adjuvant chemotherapy after laparotomy for Wilms tumor and neuroblastomaAshley E. Ross, Andrew J. Murphy, Lindsay J. Talbot et al.|Pediatric Surgery International|2021Cited by 21
Excellent Outcome for Pediatric Patients with High Risk Hodgkin Lymphoma with Brentuximab Vedotin and Risk Adapted Residual Node RadiationMonika L. Metzger, Matthew J. Krasin, Michael P. Link et al.|SSRN Electronic Journal|2020Cited by 0